1 IBS-C Drugs Market Overview 1.1 Product Overview and Scope of IBS-C Drugs 1.2 IBS-C Drugs Segment by Type 1.2.1 Global IBS-C Drugs Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Linaclotide 1.2.3 Lubiprostone 1.2.4 Osmotic Laxatives 1.2.5 Stimulant Laxatives 1.2.6 Others 1.3 IBS-C Drugs Segment by Application 1.3.1 Global IBS-C Drugs Sales Comparison by Application: (2021-2027) 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Global IBS-C Drugs Market Size Estimates and Forecasts 1.4.1 Global IBS-C Drugs Revenue 2016-2027 1.4.2 Global IBS-C Drugs Sales 2016-2027 1.4.3 IBS-C Drugs Market Size by Region: 2016 Versus 2021 Versus 2027 2 IBS-C Drugs Market Competition by Manufacturers 2.1 Global IBS-C Drugs Sales Market Share by Manufacturers (2016-2021) 2.2 Global IBS-C Drugs Revenue Market Share by Manufacturers (2016-2021) 2.3 Global IBS-C Drugs Average Price by Manufacturers (2016-2021) 2.4 Manufacturers IBS-C Drugs Manufacturing Sites, Area Served, Product Type 2.5 IBS-C Drugs Market Competitive Situation and Trends 2.5.1 IBS-C Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest IBS-C Drugs Players Market Share by Revenue 2.5.3 Global IBS-C Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 IBS-C Drugs Retrospective Market Scenario by Region 3.1 Global IBS-C Drugs Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global IBS-C Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America IBS-C Drugs Market Facts & Figures by Country 3.3.1 North America IBS-C Drugs Sales by Country 3.3.2 North America IBS-C Drugs Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe IBS-C Drugs Market Facts & Figures by Country 3.4.1 Europe IBS-C Drugs Sales by Country 3.4.2 Europe IBS-C Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific IBS-C Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific IBS-C Drugs Sales by Region 3.5.2 Asia Pacific IBS-C Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America IBS-C Drugs Market Facts & Figures by Country 3.6.1 Latin America IBS-C Drugs Sales by Country 3.6.2 Latin America IBS-C Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa IBS-C Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa IBS-C Drugs Sales by Country 3.7.2 Middle East and Africa IBS-C Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global IBS-C Drugs Historic Market Analysis by Type 4.1 Global IBS-C Drugs Sales Market Share by Type (2016-2021) 4.2 Global IBS-C Drugs Revenue Market Share by Type (2016-2021) 4.3 Global IBS-C Drugs Price by Type (2016-2021) 5 Global IBS-C Drugs Historic Market Analysis by Application 5.1 Global IBS-C Drugs Sales Market Share by Application (2016-2021) 5.2 Global IBS-C Drugs Revenue Market Share by Application (2016-2021) 5.3 Global IBS-C Drugs Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Catalent Pharmaceuticals Solutions 6.1.1 Catalent Pharmaceuticals Solutions Corporation Information 6.1.2 Catalent Pharmaceuticals Solutions Description and Business Overview 6.1.3 Catalent Pharmaceuticals Solutions IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Catalent Pharmaceuticals Solutions IBS-C Drugs Product Portfolio 6.1.5 Catalent Pharmaceuticals Solutions Recent Developments/Updates 6.2 Nestle 6.2.1 Nestle Corporation Information 6.2.2 Nestle Description and Business Overview 6.2.3 Nestle IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Nestle IBS-C Drugs Product Portfolio 6.2.5 Nestle Recent Developments/Updates 6.3 Abbott Laboratories 6.3.1 Abbott Laboratories Corporation Information 6.3.2 Abbott Laboratories Description and Business Overview 6.3.3 Abbott Laboratories IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Abbott Laboratories IBS-C Drugs Product Portfolio 6.3.5 Abbott Laboratories Recent Developments/Updates 6.4 Synergy Pharmaceuticals 6.4.1 Synergy Pharmaceuticals Corporation Information 6.4.2 Synergy Pharmaceuticals Description and Business Overview 6.4.3 Synergy Pharmaceuticals IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Synergy Pharmaceuticals IBS-C Drugs Product Portfolio 6.4.5 Synergy Pharmaceuticals Recent Developments/Updates 6.5 Sucampo Pharmaceuticals 6.5.1 Sucampo Pharmaceuticals Corporation Information 6.5.2 Sucampo Pharmaceuticals Description and Business Overview 6.5.3 Sucampo Pharmaceuticals IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Sucampo Pharmaceuticals IBS-C Drugs Product Portfolio 6.5.5 Sucampo Pharmaceuticals Recent Developments/Updates 6.6 Novartis Pharma Ag 6.6.1 Novartis Pharma Ag Corporation Information 6.6.2 Novartis Pharma Ag Description and Business Overview 6.6.3 Novartis Pharma Ag IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Novartis Pharma Ag IBS-C Drugs Product Portfolio 6.6.5 Novartis Pharma Ag Recent Developments/Updates 6.7 Astellas Pharmaceuticals 6.6.1 Astellas Pharmaceuticals Corporation Information 6.6.2 Astellas Pharmaceuticals Description and Business Overview 6.6.3 Astellas Pharmaceuticals IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Astellas Pharmaceuticals IBS-C Drugs Product Portfolio 6.7.5 Astellas Pharmaceuticals Recent Developments/Updates 6.8 Ardelyx, Inc 6.8.1 Ardelyx, Inc Corporation Information 6.8.2 Ardelyx, Inc Description and Business Overview 6.8.3 Ardelyx, Inc IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Ardelyx, Inc IBS-C Drugs Product Portfolio 6.8.5 Ardelyx, Inc Recent Developments/Updates 6.9 Synthetic Biologics, Inc 6.9.1 Synthetic Biologics, Inc Corporation Information 6.9.2 Synthetic Biologics, Inc Description and Business Overview 6.9.3 Synthetic Biologics, Inc IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Synthetic Biologics, Inc IBS-C Drugs Product Portfolio 6.9.5 Synthetic Biologics, Inc Recent Developments/Updates 6.10 Teva Pharmaceutical Industries 6.10.1 Teva Pharmaceutical Industries Corporation Information 6.10.2 Teva Pharmaceutical Industries Description and Business Overview 6.10.3 Teva Pharmaceutical Industries IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Teva Pharmaceutical Industries IBS-C Drugs Product Portfolio 6.10.5 Teva Pharmaceutical Industries Recent Developments/Updates 6.11 Bama-Geve, SLU 6.11.1 Bama-Geve, SLU Corporation Information 6.11.2 Bama-Geve, SLU IBS-C Drugs Description and Business Overview 6.11.3 Bama-Geve, SLU IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Bama-Geve, SLU IBS-C Drugs Product Portfolio 6.11.5 Bama-Geve, SLU Recent Developments/Updates 6.12 Ferring BV 6.12.1 Ferring BV Corporation Information 6.12.2 Ferring BV IBS-C Drugs Description and Business Overview 6.12.3 Ferring BV IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.12.4 Ferring BV IBS-C Drugs Product Portfolio 6.12.5 Ferring BV Recent Developments/Updates 6.13 Ironwood Pharmaceuticals, Inc 6.13.1 Ironwood Pharmaceuticals, Inc Corporation Information 6.13.2 Ironwood Pharmaceuticals, Inc IBS-C Drugs Description and Business Overview 6.13.3 Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.13.4 Ironwood Pharmaceuticals, Inc IBS-C Drugs Product Portfolio 6.13.5 Ironwood Pharmaceuticals, Inc Recent Developments/Updates 6.14 Salix Pharmaceuticals Ltd 6.14.1 Salix Pharmaceuticals Ltd Corporation Information 6.14.2 Salix Pharmaceuticals Ltd IBS-C Drugs Description and Business Overview 6.14.3 Salix Pharmaceuticals Ltd IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.14.4 Salix Pharmaceuticals Ltd IBS-C Drugs Product Portfolio 6.14.5 Salix Pharmaceuticals Ltd Recent Developments/Updates 6.15 Norgine B.V 6.15.1 Norgine B.V Corporation Information 6.15.2 Norgine B.V IBS-C Drugs Description and Business Overview 6.15.3 Norgine B.V IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.15.4 Norgine B.V IBS-C Drugs Product Portfolio 6.15.5 Norgine B.V Recent Developments/Updates 6.16 Prometheus Laboratories Inc 6.16.1 Prometheus Laboratories Inc Corporation Information 6.16.2 Prometheus Laboratories Inc IBS-C Drugs Description and Business Overview 6.16.3 Prometheus Laboratories Inc IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.16.4 Prometheus Laboratories Inc IBS-C Drugs Product Portfolio 6.16.5 Prometheus Laboratories Inc Recent Developments/Updates 6.17 Actavis Nordic A/S 6.17.1 Actavis Nordic A/S Corporation Information 6.17.2 Actavis Nordic A/S IBS-C Drugs Description and Business Overview 6.17.3 Actavis Nordic A/S IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.17.4 Actavis Nordic A/S IBS-C Drugs Product Portfolio 6.17.5 Actavis Nordic A/S Recent Developments/Updates 6.18 Albireo Pharma Inc 6.18.1 Albireo Pharma Inc Corporation Information 6.18.2 Albireo Pharma Inc IBS-C Drugs Description and Business Overview 6.18.3 Albireo Pharma Inc IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.18.4 Albireo Pharma Inc IBS-C Drugs Product Portfolio 6.18.5 Albireo Pharma Inc Recent Developments/Updates 6.19 Yuhan Corp 6.19.1 Yuhan Corp Corporation Information 6.19.2 Yuhan Corp IBS-C Drugs Description and Business Overview 6.19.3 Yuhan Corp IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.19.4 Yuhan Corp IBS-C Drugs Product Portfolio 6.19.5 Yuhan Corp Recent Developments/Updates 6.20 Astrazeneca Plc 6.20.1 Astrazeneca Plc Corporation Information 6.20.2 Astrazeneca Plc IBS-C Drugs Description and Business Overview 6.20.3 Astrazeneca Plc IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.20.4 Astrazeneca Plc IBS-C Drugs Product Portfolio 6.20.5 Astrazeneca Plc Recent Developments/Updates 6.21 The Menarini Group 6.21.1 The Menarini Group Corporation Information 6.21.2 The Menarini Group IBS-C Drugs Description and Business Overview 6.21.3 The Menarini Group IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.21.4 The Menarini Group IBS-C Drugs Product Portfolio 6.21.5 The Menarini Group Recent Developments/Updates 6.22 Ono Pharmaceutical Co., Ltd 6.22.1 Ono Pharmaceutical Co., Ltd Corporation Information 6.22.2 Ono Pharmaceutical Co., Ltd IBS-C Drugs Description and Business Overview 6.22.3 Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales, Revenue and Gross Margin (2016-2021) 6.22.4 Ono Pharmaceutical Co., Ltd IBS-C Drugs Product Portfolio 6.22.5 Ono Pharmaceutical Co., Ltd Recent Developments/Updates 7 IBS-C Drugs Manufacturing Cost Analysis 7.1 IBS-C Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of IBS-C Drugs 7.4 IBS-C Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 IBS-C Drugs Distributors List 8.3 IBS-C Drugs Customers 9 IBS-C Drugs Market Dynamics 9.1 IBS-C Drugs Industry Trends 9.2 IBS-C Drugs Growth Drivers 9.3 IBS-C Drugs Market Challenges 9.4 IBS-C Drugs Market Restraints 10 Global Market Forecast 10.1 IBS-C Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of IBS-C Drugs by Type (2022-2027) 10.1.2 Global Forecasted Revenue of IBS-C Drugs by Type (2022-2027) 10.2 IBS-C Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of IBS-C Drugs by Application (2022-2027) 10.2.2 Global Forecasted Revenue of IBS-C Drugs by Application (2022-2027) 10.3 IBS-C Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of IBS-C Drugs by Region (2022-2027) 10.3.2 Global Forecasted Revenue of IBS-C Drugs by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global IBS-C Drugs Sales (K Pcs) Growth Rate Comparison by Type (2021-2027) Table 2. Global IBS-C Drugs Sales (K Pcs) Comparison by Application (2021-2027) Table 3. Global IBS-C Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers IBS-C Drugs Covered in This Study Table 5. Global IBS-C Drugs Sales (K Pcs) of Key Manufacturers (2016-2021) Table 6. Global IBS-C Drugs Sales Market Share by Manufacturers (2016-2021) Table 7. Global IBS-C Drugs Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global IBS-C Drugs Revenue Share by Manufacturers (2016-2021) Table 9. Global Market IBS-C Drugs Average Price (USD/Pcs) of Key Manufacturers (2016-2021) Table 10. Manufacturers IBS-C Drugs Manufacturing Sites and Area Served Table 11. Manufacturers IBS-C Drugs Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global IBS-C Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IBS-C Drugs as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global IBS-C Drugs Sales by Region (2016-2021) & (K Pcs) Table 16. Global IBS-C Drugs Sales Market Share by Region (2016-2021) Table 17. Global IBS-C Drugs Revenue by Region (2016-2021) & (US$ Million) Table 18. North America IBS-C Drugs Sales by Country (2016-2021) & (K Pcs) Table 19. North America IBS-C Drugs Sales Market Share by Country (2016-2021) Table 20. North America IBS-C Drugs Revenue by Country (2016-2021) & (US$ Million) Table 21. North America IBS-C Drugs Revenue Market Share by Country (2016-2021) Table 22. Europe IBS-C Drugs Sales by Country (2016-2021) & (K Pcs) Table 23. Europe IBS-C Drugs Sales Market Share by Country (2016-2021) Table 24. Europe IBS-C Drugs Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe IBS-C Drugs Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific IBS-C Drugs Sales by Region (2016-2021) & (K Pcs) Table 27. Asia Pacific IBS-C Drugs Sales Market Share by Region (2016-2021) Table 28. Asia Pacific IBS-C Drugs Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific IBS-C Drugs Revenue Market Share by Region (2016-2021) Table 30. Latin America IBS-C Drugs Sales by Country (2016-2021) & (K Pcs) Table 31. Latin America IBS-C Drugs Sales Market Share by Country (2016-2021) Table 32. Latin America IBS-C Drugs Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America IBS-C Drugs Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa IBS-C Drugs Sales by Country (2016-2021) & (K Pcs) Table 35. Middle East and Africa IBS-C Drugs Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa IBS-C Drugs Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa IBS-C Drugs Revenue Market Share by Country (2016-2021) Table 38. Global IBS-C Drugs Sales (K Pcs) by Type (2016-2021) Table 39. Global IBS-C Drugs Sales Market Share by Type (2016-2021) Table 40. Global IBS-C Drugs Revenue (Million US$) by Type (2016-2021) Table 41. Global IBS-C Drugs Revenue Share by Type (2016-2021) Table 42. Global IBS-C Drugs Price (USD/Pcs) by Type (2016-2021) Table 43. Global IBS-C Drugs Sales (K Pcs) by Application (2016-2021) Table 44. Global IBS-C Drugs Sales Market Share by Application (2016-2021) Table 45. Global IBS-C Drugs Revenue (Million US$) by Application (2016-2021) Table 46. Global IBS-C Drugs Revenue Share by Application (2016-2021) Table 47. Global IBS-C Drugs Price (USD/Pcs) by Application (2016-2021) Table 48. Catalent Pharmaceuticals Solutions Corporation Information Table 49. Catalent Pharmaceuticals Solutions Description and Business Overview Table 50. Catalent Pharmaceuticals Solutions IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 51. Catalent Pharmaceuticals Solutions IBS-C Drugs Product Table 52. Catalent Pharmaceuticals Solutions Recent Developments/Updates Table 53. Nestle Corporation Information Table 54. Nestle Description and Business Overview Table 55. Nestle IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 56. Nestle IBS-C Drugs Product Table 57. Nestle Recent Developments/Updates Table 58. Abbott Laboratories Corporation Information Table 59. Abbott Laboratories Description and Business Overview Table 60. Abbott Laboratories IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 61. Abbott Laboratories IBS-C Drugs Product Table 62. Abbott Laboratories Recent Developments/Updates Table 63. Synergy Pharmaceuticals Corporation Information Table 64. Synergy Pharmaceuticals Description and Business Overview Table 65. Synergy Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 66. Synergy Pharmaceuticals IBS-C Drugs Product Table 67. Synergy Pharmaceuticals Recent Developments/Updates Table 68. Sucampo Pharmaceuticals Corporation Information Table 69. Sucampo Pharmaceuticals Description and Business Overview Table 70. Sucampo Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 71. Sucampo Pharmaceuticals IBS-C Drugs Product Table 72. Sucampo Pharmaceuticals Recent Developments/Updates Table 73. Novartis Pharma Ag Corporation Information Table 74. Novartis Pharma Ag Description and Business Overview Table 75. Novartis Pharma Ag IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 76. Novartis Pharma Ag IBS-C Drugs Product Table 77. Novartis Pharma Ag Recent Developments/Updates Table 78. Astellas Pharmaceuticals Corporation Information Table 79. Astellas Pharmaceuticals Description and Business Overview Table 80. Astellas Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 81. Astellas Pharmaceuticals IBS-C Drugs Product Table 82. Astellas Pharmaceuticals Recent Developments/Updates Table 83. Ardelyx, Inc Corporation Information Table 84. Ardelyx, Inc Description and Business Overview Table 85. Ardelyx, Inc IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 86. Ardelyx, Inc IBS-C Drugs Product Table 87. Ardelyx, Inc Recent Developments/Updates Table 88. Synthetic Biologics, Inc Corporation Information Table 89. Synthetic Biologics, Inc Description and Business Overview Table 90. Synthetic Biologics, Inc IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 91. Synthetic Biologics, Inc IBS-C Drugs Product Table 92. Synthetic Biologics, Inc Recent Developments/Updates Table 93. Teva Pharmaceutical Industries Corporation Information Table 94. Teva Pharmaceutical Industries Description and Business Overview Table 95. Teva Pharmaceutical Industries IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 96. Teva Pharmaceutical Industries IBS-C Drugs Product Table 97. Teva Pharmaceutical Industries Recent Developments/Updates Table 98. Bama-Geve, SLU Corporation Information Table 99. Bama-Geve, SLU Description and Business Overview Table 100. Bama-Geve, SLU IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 101. Bama-Geve, SLU IBS-C Drugs Product Table 102. Bama-Geve, SLU Recent Developments/Updates Table 103. Ferring BV Corporation Information Table 104. Ferring BV Description and Business Overview Table 105. Ferring BV IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 106. Ferring BV IBS-C Drugs Product Table 107. Ferring BV Recent Developments/Updates Table 108. Ironwood Pharmaceuticals, Inc Corporation Information Table 109. Ironwood Pharmaceuticals, Inc Description and Business Overview Table 110. Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 111. Ironwood Pharmaceuticals, Inc IBS-C Drugs Product Table 112. Ironwood Pharmaceuticals, Inc Recent Developments/Updates Table 113. Salix Pharmaceuticals Ltd Corporation Information Table 114. Salix Pharmaceuticals Ltd Description and Business Overview Table 115. Salix Pharmaceuticals Ltd IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 116. Salix Pharmaceuticals Ltd IBS-C Drugs Product Table 117. Salix Pharmaceuticals Ltd Recent Developments/Updates Table 118. Norgine B.V Corporation Information Table 119. Norgine B.V Description and Business Overview Table 120. Norgine B.V IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 121. Norgine B.V IBS-C Drugs Product Table 122. Norgine B.V Recent Developments/Updates Table 123. Prometheus Laboratories Inc Corporation Information Table 124. Prometheus Laboratories Inc Description and Business Overview Table 125. Prometheus Laboratories Inc IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 126. Prometheus Laboratories Inc IBS-C Drugs Product Table 127. Prometheus Laboratories Inc Recent Developments/Updates Table 128. Actavis Nordic A/S Corporation Information Table 129. Actavis Nordic A/S Description and Business Overview Table 130. Actavis Nordic A/S IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 131. Actavis Nordic A/S IBS-C Drugs Product Table 132. Actavis Nordic A/S Recent Developments/Updates Table 133. Albireo Pharma Inc Corporation Information Table 134. Albireo Pharma Inc Description and Business Overview Table 135. Albireo Pharma Inc IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 136. Albireo Pharma Inc IBS-C Drugs Product Table 137. Albireo Pharma Inc Recent Developments/Updates Table 138. Yuhan Corp Corporation Information Table 139. Yuhan Corp Description and Business Overview Table 140. Yuhan Corp IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 141. Yuhan Corp IBS-C Drugs Product Table 142. Yuhan Corp Recent Developments/Updates Table 143. Astrazeneca Plc Corporation Information Table 144. Astrazeneca Plc Description and Business Overview Table 145. Astrazeneca Plc IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 146. Astrazeneca Plc IBS-C Drugs Product Table 147. Astrazeneca Plc Recent Developments/Updates Table 148. The Menarini Group Corporation Information Table 149. The Menarini Group Description and Business Overview Table 150. The Menarini Group IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 151. The Menarini Group IBS-C Drugs Product Table 152. The Menarini Group Recent Developments/Updates Table 153. Ono Pharmaceutical Co., Ltd Corporation Information Table 154. Ono Pharmaceutical Co., Ltd Description and Business Overview Table 155. Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 156. Ono Pharmaceutical Co., Ltd IBS-C Drugs Product Table 157. Ono Pharmaceutical Co., Ltd Recent Developments/Updates Table 158. Production Base and Market Concentration Rate of Raw Material Table 159. Key Suppliers of Raw Materials Table 160. IBS-C Drugs Distributors List Table 161. IBS-C Drugs Customers List Table 162. IBS-C Drugs Market Trends Table 163. IBS-C Drugs Growth Drivers Table 164. IBS-C Drugs Market Challenges Table 165. IBS-C Drugs Market Restraints Table 166. Global IBS-C Drugs Sales Forecast by Type (2022-2027) & (K Pcs) Table 167. Global IBS-C Drugs Sales Market Share Forecast by Type (2022-2027) Table 168. Global IBS-C Drugs Revenue Forecast by Type (2022-2027) & (US$ Million) Table 169. Global IBS-C Drugs Revenue Market Share Forecast by Type (2022-2027) Table 170. Global IBS-C Drugs Sales Forecast by Application (2022-2027) & (K Pcs) Table 171. Global IBS-C Drugs Sales Market Share Forecast by Application (2022-2027) Table 172. Global IBS-C Drugs Revenue Forecast by Application (2022-2027) & (US$ Million) Table 173. Global IBS-C Drugs Revenue Market Share Forecast by Application (2022-2027) Table 174. Global IBS-C Drugs Sales Forecast by Region (2022-2027) & (K Pcs) Table 175. Global IBS-C Drugs Sales Market Share Forecast by Region (2022-2027) Table 176. Global IBS-C Drugs Revenue Forecast by Region (2022-2027) & (US$ Million) Table 177. Global IBS-C Drugs Revenue Market Share Forecast by Region (2022-2027) Table 178. Research Programs/Design for This Report Table 179. Key Data Information from Secondary Sources Table 180. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of IBS-C Drugs Figure 2. Global IBS-C Drugs Market Share by Type in 2020 & 2027 Figure 3. Linaclotide Product Picture Figure 4. Lubiprostone Product Picture Figure 5. Osmotic Laxatives Product Picture Figure 6. Stimulant Laxatives Product Picture Figure 7. Others Product Picture Figure 8. Global IBS-C Drugs Market Share by Application in 2020 & 2027 Figure 9. Hospital Pharmacies Figure 10. Retail Pharmacies Figure 11. Online Pharmacies Figure 12. Global IBS-C Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global IBS-C Drugs Market Size 2016-2027 (US$ Million) Figure 14. Global IBS-C Drugs Sales 2016-2027 (K Pcs) Figure 15. Global IBS-C Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 16. IBS-C Drugs Sales Share by Manufacturers in 2020 Figure 17. Global IBS-C Drugs Revenue Share by Manufacturers in 2020 Figure 18. The Global 5 and 10 Largest IBS-C Drugs Players: Market Share by Revenue in 2020 Figure 19. IBS-C Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 20. Global IBS-C Drugs Sales Market Share by Region (2016-2021) Figure 21. Global IBS-C Drugs Sales Market Share by Region in 2020 Figure 22. Global IBS-C Drugs Revenue Market Share by Region (2016-2021) Figure 23. Global IBS-C Drugs Revenue Market Share by Region in 2020 Figure 24. U.S. IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Canada IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Germany IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. France IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. U.K. IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Italy IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Russia IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. China IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Japan IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. South Korea IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. India IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Australia IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Taiwan IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Indonesia IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Thailand IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Malaysia IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Philippines IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Vietnam IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Mexico IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Brazil IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Argentina IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Turkey IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Saudi Arabia IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. U.A.E IBS-C Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Sales Market Share of IBS-C Drugs by Type (2016-2021) Figure 49. Sales Market Share of IBS-C Drugs by Application (2016-2021) Figure 50. Sales Market Share of IBS-C Drugs by Application in 2020 Figure 51. Revenue Share of IBS-C Drugs by Application (2016-2021) Figure 52. Revenue Share of IBS-C Drugs by Application in 2020 Figure 53. Manufacturing Cost Structure of IBS-C Drugs Figure 54. Manufacturing Process Analysis of IBS-C Drugs Figure 55. IBS-C Drugs Industrial Chain Analysis Figure 56. Channels of Distribution Figure 57. Distributors Profiles Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed